Webb Ding

APAC region operation covering China, Taiwan, Hong Kong, Korea, Australia and New Zealand.

Global commercial strategy and China opportunity’s of NewCo setting up.

Fresenuis-Kabi China is a leading MNC pharmaceutical company focusing on medical nutrition, critical illness and chronic disease area by providing both high quality medicine and medical device, with annual revenue around 7bn RMB and ranking at No. 9 among all MNC pharmaceuticals. 6000 talented people and 5 advanced manufacture sites with 3 I&D centers lay good fundation for future growth. Keep growing both on business and people development is our commitment.

Responsible to drive business through development of strategy, improvement of operation and shaping culture for high engagement. Leading an organization with market leader position at Medical nutrition, Anesthesia & Surgery, and Nephrology.

Accountable for developing Novartis vaccine business in Greater China, leading integration process of acquired Tianyuan Bio-pharma. Driving Operational Excellence initiatives implementation in all functions, such as Techops, Quality organization, R&D and Commercial organization, etc. In short term, to upgrade quality control and to establish compliance culture, in long term, to have tech-transfer and develop new product locally, as well as tremendously develop export business after WHO PQ.

LEADERSHIP: A) increasing responsibility to manage a team with more than 700 staff, broadened portfolio covering 10 theraphy areas, sophisticated FF architecture of 13 kinds of promotion line. B) efficiently align whole executive committee team to drive business, strong professional&passionate culture with customer focus as cornstone across functions such as Marketing, Medical, HR, Finance, Market access, KAM, Sales Operation, Compliance, etc. C) clear vision to team and realistically leading to go through periodic goal step by step, based on true judgement of enxternal and internal situation. CHANGE MANAGEMENT: Good learning and practice in a huge org change and leader change in 12 months, Org designing, R&R defining, People endorsement and engagement, Comprehensive communication, Driving quick win, Culture reshaping, etc. HIGH PERFORMING: consistenly hit number and win competetion to gain market share in GenM with no disruption during the huge org change, lower than industry people turnover and high team morale and engagement.

SUCCESS NEW LAUNCH: leading an ever best new launch in Novartis China by starting from a brand new BU set up for new TA of hepatitis disease. An incubator of future leaders with lots of them growing to be cornerstone of business leader at HBV/HCV in different company. CRISIS MANAGEMENT: great experience to succeed in serious crisis, with strong support from global and local cross function team

OTC & PRIMARY CARE: lead OTC team for 18 months then moved to lead primary care hospital sales team, good experience bridging across different type of business SUCCESS TO NO.1: success in taking opportunity of new listing of RDL. Set ambitous goal and achieved to lead Diovan to No.1. ARB in China market.

LOCAL PRACTICE: brand new experience to do business in local practice, succeeded to reshape business model to be more effective and efficiency

WIN IN FRONTIER: built up comprehensive 1st hand knowledge and exprience of frontier management and competition